$9.94
+2.1%Varex Imaging Corporation designs and manufactures X-ray imaging components. The company operates in two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, 3D reconstruction and computer-aided diagnostic software, collimators, automatic exposure control devices, generators, heat exchangers, ionization chambers, and buckys. This segment's products are used in a range of applications, including radiographic and fluoroscopic imaging, mammography, computed tomography, radiation therapy, oncology, CT, cardiac, surgery, dental, computer-aided detection, and other diagnostic radiography uses. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital detectors, and high voltage connectors for use in security and industrial inspection applications, such as airport security, cargo screening at ports and borders, and nondestructive testing and examination in various applications. Varex Imaging Corporation sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. The company has operations in North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Varex Imaging Corporation was founded in 2016 and is based in Salt Lake City, Utah.
Last Annual Value
-31.40M
3-Year CAGR
12%
5-Year CAGR
6%
10-Year CAGR
-5%
| Company | Total Other Income Expenses Net | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
![]() Varex Imaging Corporation NASDAQ:VREX | -31.40M | N/A | N/A | N/A | |
![]() Avanos Medical, Inc. NYSE:AVNS | -4.60M | N/A | N/A | N/A | |
![]() Lexicon Pharmaceuticals, Inc. NASDAQ:LXRX | -1.43M | N/A | N/A | N/A | |
![]() Cullinan Therapeutics, Inc. NASDAQ:CGEM | 21.77M | -0.1% | 115.4% | N/A | |
![]() CeriBell, Inc. NASDAQ:CBLL | 4.99M | 104.0% | N/A | N/A | |
![]() Cytek Biosciences, Inc. NASDAQ:CTKB | 10.54M | -4.6% | N/A | N/A | |
![]() Standard BioTools Inc. NASDAQ:LAB | -3.40M | N/A | N/A | N/A | |
![]() Omeros Corporation NASDAQ:OMER | 120.00M | N/A | N/A | N/A | |
![]() Orthofix Medical Inc. NASDAQ:OFIX | -22.34M | N/A | N/A | N/A |
Continue your VREX research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.